Search | Page 2 | Aplastic Anemia and MDS International Foundation


Search results

  1. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... complete remission (CR) High-risk MDS status-post cytotoxic chemotherapy Burkitt's lymphoma: second or subsequent CR ... lymphomas that have failed at least 1 prior regimen of multi-agent chemotherapy and are ineligible for an autologous transplant Marginal ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.

  2. MDS - Treatment (OLD)

    ... (Revlimid®), which is considered an immunomodulatry agent. For patients in Europe, note that the European Agency for the ... shape or look. Chemotherapy for MDS patients involves cytotoxic agents which kill cells. They are divided into low-dose and high-dose ...

    Topic section last updated 03/10/2016 - 11:01pm.